The global market for Swine Pseudorabies Vaccine was valued at US$ 613 million in the year 2024 and is projected to reach a revised size of US$ 809 million by 2031, growing at a CAGR of 4.1% during the forecast period.

Swine Pseudorabies Vaccine Market

Biological products for preventing pseudorabies in pigs

The growth and development of the swine industry, especially in regions with high pork consumption, has boosted the demand for porcine pseudorabies vaccine. As hog production expands to meet the growing demand for pork products, the need for effective disease prevention measures, including vaccination, becomes more important, which is driving the porcine pseudorabies vaccine market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Swine Pseudorabies Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Swine Pseudorabies Vaccine.

The Swine Pseudorabies Vaccine market size, estimations, and forecasts are provided in terms of sales volume (Box) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Swine Pseudorabies Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Swine Pseudorabies Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Swine Pseudorabies Vaccine Market Report

Report Metric	Details
Report Name	Swine Pseudorabies Vaccine Market
Accounted market size in year	US$ 613 million
Forecasted market size in 2031	US$ 809 million
CAGR	4.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Swine Pseudorabies Vaccine , Live Swine Pseudorabies　Vaccine, Inactivated
Segment by Application	Farms Individual
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Keqian Biology, Zybio, Jinyu Biology, Cahic, Pulike Biology, Hayao, Qilu Animal Protection, Dahuanong, Huapai Biotechnology, Sinopharm Animal Health, Tecon, Zoetis, Boehringer Ingelheim, Bayer
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Swine Pseudorabies Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Swine Pseudorabies Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Swine Pseudorabies Vaccine Market growing?

Ans: The Swine Pseudorabies Vaccine Market witnessing a CAGR of 4.1% during the forecast period 2025-2031.

What is the Swine Pseudorabies Vaccine Market size in 2031?

Ans: The Swine Pseudorabies Vaccine Market size in 2031 will be US$ 809 million.

Who are the main players in the Swine Pseudorabies Vaccine Market report?

Ans: The main players in the Swine Pseudorabies Vaccine Market are Keqian Biology, Zybio, Jinyu Biology, Cahic, Pulike Biology, Hayao, Qilu Animal Protection, Dahuanong, Huapai Biotechnology, Sinopharm Animal Health, Tecon, Zoetis, Boehringer Ingelheim, Bayer

What are the Application segmentation covered in the Swine Pseudorabies Vaccine Market report?

Ans: The Applications covered in the Swine Pseudorabies Vaccine Market report are Farms, Individual

What are the Type segmentation covered in the Swine Pseudorabies Vaccine Market report?

Ans: The Types covered in the Swine Pseudorabies Vaccine Market report are Swine Pseudorabies Vaccine , Live, Swine Pseudorabies　Vaccine, Inactivated

1 Swine Pseudorabies Vaccine Market Overview

1.1 Product Definition

1.2 Swine Pseudorabies Vaccine by Type

1.2.1 Global Swine Pseudorabies Vaccine Market Value Comparison by Type (2024 VS 2031)

1.2.2 Swine Pseudorabies Vaccine , Live

1.2.3 Swine Pseudorabies　Vaccine, Inactivated

1.3 Swine Pseudorabies Vaccine by Application

1.3.1 Global Swine Pseudorabies Vaccine Market Value by Application (2024 VS 2031)

1.3.2 Farms

1.3.3 Individual

1.4 Global Swine Pseudorabies Vaccine Market Size Estimates and Forecasts

1.4.1 Global Swine Pseudorabies Vaccine Revenue 2020-2031

1.4.2 Global Swine Pseudorabies Vaccine Sales 2020-2031

1.4.3 Global Swine Pseudorabies Vaccine Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Swine Pseudorabies Vaccine Market Competition by Manufacturers

2.1 Global Swine Pseudorabies Vaccine Sales Market Share by Manufacturers (2020-2025)

2.2 Global Swine Pseudorabies Vaccine Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Swine Pseudorabies Vaccine Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Swine Pseudorabies Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Swine Pseudorabies Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Swine Pseudorabies Vaccine, Product Type & Application

2.7 Global Key Manufacturers of Swine Pseudorabies Vaccine, Date of Enter into This Industry

2.8 Global Swine Pseudorabies Vaccine Market Competitive Situation and Trends

2.8.1 Global Swine Pseudorabies Vaccine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Swine Pseudorabies Vaccine Players Market Share by Revenue

2.8.3 Global Swine Pseudorabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Swine Pseudorabies Vaccine Market Scenario by Region

3.1 Global Swine Pseudorabies Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Swine Pseudorabies Vaccine Sales by Region: 2020-2031

3.2.1 Global Swine Pseudorabies Vaccine Sales by Region: 2020-2025

3.2.2 Global Swine Pseudorabies Vaccine Sales by Region: 2026-2031

3.3 Global Swine Pseudorabies Vaccine Revenue by Region: 2020-2031

3.3.1 Global Swine Pseudorabies Vaccine Revenue by Region: 2020-2025

3.3.2 Global Swine Pseudorabies Vaccine Revenue by Region: 2026-2031

3.4 North America Swine Pseudorabies Vaccine Market Facts & Figures by Country

3.4.1 North America Swine Pseudorabies Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Swine Pseudorabies Vaccine Sales by Country (2020-2031)

3.4.3 North America Swine Pseudorabies Vaccine Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Swine Pseudorabies Vaccine Market Facts & Figures by Country

3.5.1 Europe Swine Pseudorabies Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Swine Pseudorabies Vaccine Sales by Country (2020-2031)

3.5.3 Europe Swine Pseudorabies Vaccine Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Swine Pseudorabies Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific Swine Pseudorabies Vaccine Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Swine Pseudorabies Vaccine Sales by Region (2020-2031)

3.6.3 Asia Pacific Swine Pseudorabies Vaccine Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Swine Pseudorabies Vaccine Market Facts & Figures by Country

3.7.1 Latin America Swine Pseudorabies Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Swine Pseudorabies Vaccine Sales by Country (2020-2031)

3.7.3 Latin America Swine Pseudorabies Vaccine Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Swine Pseudorabies Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Swine Pseudorabies Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Swine Pseudorabies Vaccine Sales by Country (2020-2031)

3.8.3 Middle East and Africa Swine Pseudorabies Vaccine Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Swine Pseudorabies Vaccine Sales by Type (2020-2031)

4.1.1 Global Swine Pseudorabies Vaccine Sales by Type (2020-2025)

4.1.2 Global Swine Pseudorabies Vaccine Sales by Type (2026-2031)

4.1.3 Global Swine Pseudorabies Vaccine Sales Market Share by Type (2020-2031)

4.2 Global Swine Pseudorabies Vaccine Revenue by Type (2020-2031)

4.2.1 Global Swine Pseudorabies Vaccine Revenue by Type (2020-2025)

4.2.2 Global Swine Pseudorabies Vaccine Revenue by Type (2026-2031)

4.2.3 Global Swine Pseudorabies Vaccine Revenue Market Share by Type (2020-2031)

4.3 Global Swine Pseudorabies Vaccine Price by Type (2020-2031)

5 Segment by Application

5.1 Global Swine Pseudorabies Vaccine Sales by Application (2020-2031)

5.1.1 Global Swine Pseudorabies Vaccine Sales by Application (2020-2025)

5.1.2 Global Swine Pseudorabies Vaccine Sales by Application (2026-2031)

5.1.3 Global Swine Pseudorabies Vaccine Sales Market Share by Application (2020-2031)

5.2 Global Swine Pseudorabies Vaccine Revenue by Application (2020-2031)

5.2.1 Global Swine Pseudorabies Vaccine Revenue by Application (2020-2025)

5.2.2 Global Swine Pseudorabies Vaccine Revenue by Application (2026-2031)

5.2.3 Global Swine Pseudorabies Vaccine Revenue Market Share by Application (2020-2031)

5.3 Global Swine Pseudorabies Vaccine Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Keqian Biology

6.1.1 Keqian Biology Company Information

6.1.2 Keqian Biology Description and Business Overview

6.1.3 Keqian Biology Swine Pseudorabies Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Keqian Biology Swine Pseudorabies Vaccine Product Portfolio

6.1.5 Keqian Biology Recent Developments/Updates

6.2 Zybio

6.2.1 Zybio Company Information

6.2.2 Zybio Description and Business Overview

6.2.3 Zybio Swine Pseudorabies Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Zybio Swine Pseudorabies Vaccine Product Portfolio

6.2.5 Zybio Recent Developments/Updates

6.3 Jinyu Biology

6.3.1 Jinyu Biology Company Information

6.3.2 Jinyu Biology Description and Business Overview

6.3.3 Jinyu Biology Swine Pseudorabies Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Jinyu Biology Swine Pseudorabies Vaccine Product Portfolio

6.3.5 Jinyu Biology Recent Developments/Updates

6.4 Cahic

6.4.1 Cahic Company Information

6.4.2 Cahic Description and Business Overview

6.4.3 Cahic Swine Pseudorabies Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Cahic Swine Pseudorabies Vaccine Product Portfolio

6.4.5 Cahic Recent Developments/Updates

6.5 Pulike Biology

6.5.1 Pulike Biology Company Information

6.5.2 Pulike Biology Description and Business Overview

6.5.3 Pulike Biology Swine Pseudorabies Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Pulike Biology Swine Pseudorabies Vaccine Product Portfolio

6.5.5 Pulike Biology Recent Developments/Updates

6.6 Hayao

6.6.1 Hayao Company Information

6.6.2 Hayao Description and Business Overview

6.6.3 Hayao Swine Pseudorabies Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Hayao Swine Pseudorabies Vaccine Product Portfolio

6.6.5 Hayao Recent Developments/Updates

6.7 Qilu Animal Protection

6.7.1 Qilu Animal Protection Company Information

6.7.2 Qilu Animal Protection Description and Business Overview

6.7.3 Qilu Animal Protection Swine Pseudorabies Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Qilu Animal Protection Swine Pseudorabies Vaccine Product Portfolio

6.7.5 Qilu Animal Protection Recent Developments/Updates

6.8 Dahuanong

6.8.1 Dahuanong Company Information

6.8.2 Dahuanong Description and Business Overview

6.8.3 Dahuanong Swine Pseudorabies Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Dahuanong Swine Pseudorabies Vaccine Product Portfolio

6.8.5 Dahuanong Recent Developments/Updates

6.9 Huapai Biotechnology

6.9.1 Huapai Biotechnology Company Information

6.9.2 Huapai Biotechnology Description and Business Overview

6.9.3 Huapai Biotechnology Swine Pseudorabies Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Huapai Biotechnology Swine Pseudorabies Vaccine Product Portfolio

6.9.5 Huapai Biotechnology Recent Developments/Updates

6.10 Sinopharm Animal Health

6.10.1 Sinopharm Animal Health Company Information

6.10.2 Sinopharm Animal Health Description and Business Overview

6.10.3 Sinopharm Animal Health Swine Pseudorabies Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Sinopharm Animal Health Swine Pseudorabies Vaccine Product Portfolio

6.10.5 Sinopharm Animal Health Recent Developments/Updates

6.11 Tecon

6.11.1 Tecon Company Information

6.11.2 Tecon Description and Business Overview

6.11.3 Tecon Swine Pseudorabies Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Tecon Swine Pseudorabies Vaccine Product Portfolio

6.11.5 Tecon Recent Developments/Updates

6.12 Zoetis

6.12.1 Zoetis Company Information

6.12.2 Zoetis Description and Business Overview

6.12.3 Zoetis Swine Pseudorabies Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Zoetis Swine Pseudorabies Vaccine Product Portfolio

6.12.5 Zoetis Recent Developments/Updates

6.13 Boehringer Ingelheim

6.13.1 Boehringer Ingelheim Company Information

6.13.2 Boehringer Ingelheim Description and Business Overview

6.13.3 Boehringer Ingelheim Swine Pseudorabies Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Boehringer Ingelheim Swine Pseudorabies Vaccine Product Portfolio

6.13.5 Boehringer Ingelheim Recent Developments/Updates

6.14 Bayer

6.14.1 Bayer Company Information

6.14.2 Bayer Description and Business Overview

6.14.3 Bayer Swine Pseudorabies Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Bayer Swine Pseudorabies Vaccine Product Portfolio

6.14.5 Bayer Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Swine Pseudorabies Vaccine Industry Chain Analysis

7.2 Swine Pseudorabies Vaccine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Swine Pseudorabies Vaccine Production Mode & Process Analysis

7.4 Swine Pseudorabies Vaccine Sales and Marketing

7.4.1 Swine Pseudorabies Vaccine Sales Channels

7.4.2 Swine Pseudorabies Vaccine Distributors

7.5 Swine Pseudorabies Vaccine Customer Analysis

8 Swine Pseudorabies Vaccine Market Dynamics

8.1 Swine Pseudorabies Vaccine Industry Trends

8.2 Swine Pseudorabies Vaccine Market Drivers

8.3 Swine Pseudorabies Vaccine Market Challenges

8.4 Swine Pseudorabies Vaccine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Qilu Animal Protection

Huapai Biotechnology

Sinopharm Animal Health

Bayer

Boehringer Ingelheim

List of Tables

Table 1. Global Swine Pseudorabies Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Swine Pseudorabies Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Swine Pseudorabies Vaccine Market Competitive Situation by Manufacturers in 2024

Table 4. Global Swine Pseudorabies Vaccine Sales (Box) of Key Manufacturers (2020-2025)

Table 5. Global Swine Pseudorabies Vaccine Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Swine Pseudorabies Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Swine Pseudorabies Vaccine Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Swine Pseudorabies Vaccine Average Price (US$/Box) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Swine Pseudorabies Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Swine Pseudorabies Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Swine Pseudorabies Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Swine Pseudorabies Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Swine Pseudorabies Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Swine Pseudorabies Vaccine as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Swine Pseudorabies Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Swine Pseudorabies Vaccine Sales by Region (2020-2025) & (Box)

Table 18. Global Swine Pseudorabies Vaccine Sales Market Share by Region (2020-2025)

Table 19. Global Swine Pseudorabies Vaccine Sales by Region (2026-2031) & (Box)

Table 20. Global Swine Pseudorabies Vaccine Sales Market Share by Region (2026-2031)

Table 21. Global Swine Pseudorabies Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Swine Pseudorabies Vaccine Revenue Market Share by Region (2020-2025)

Table 23. Global Swine Pseudorabies Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Swine Pseudorabies Vaccine Revenue Market Share by Region (2026-2031)

Table 25. North America Swine Pseudorabies Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Swine Pseudorabies Vaccine Sales by Country (2020-2025) & (Box)

Table 27. North America Swine Pseudorabies Vaccine Sales by Country (2026-2031) & (Box)

Table 28. North America Swine Pseudorabies Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Swine Pseudorabies Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Swine Pseudorabies Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Swine Pseudorabies Vaccine Sales by Country (2020-2025) & (Box)

Table 32. Europe Swine Pseudorabies Vaccine Sales by Country (2026-2031) & (Box)

Table 33. Europe Swine Pseudorabies Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Swine Pseudorabies Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Swine Pseudorabies Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Swine Pseudorabies Vaccine Sales by Region (2020-2025) & (Box)

Table 37. Asia Pacific Swine Pseudorabies Vaccine Sales by Region (2026-2031) & (Box)

Table 38. Asia Pacific Swine Pseudorabies Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Swine Pseudorabies Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Swine Pseudorabies Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Swine Pseudorabies Vaccine Sales by Country (2020-2025) & (Box)

Table 42. Latin America Swine Pseudorabies Vaccine Sales by Country (2026-2031) & (Box)

Table 43. Latin America Swine Pseudorabies Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Swine Pseudorabies Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Swine Pseudorabies Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Swine Pseudorabies Vaccine Sales by Country (2020-2025) & (Box)

Table 47. Middle East and Africa Swine Pseudorabies Vaccine Sales by Country (2026-2031) & (Box)

Table 48. Middle East and Africa Swine Pseudorabies Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Swine Pseudorabies Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Swine Pseudorabies Vaccine Sales (Box) by Type (2020-2025)

Table 51. Global Swine Pseudorabies Vaccine Sales (Box) by Type (2026-2031)

Table 52. Global Swine Pseudorabies Vaccine Sales Market Share by Type (2020-2025)

Table 53. Global Swine Pseudorabies Vaccine Sales Market Share by Type (2026-2031)

Table 54. Global Swine Pseudorabies Vaccine Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Swine Pseudorabies Vaccine Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Swine Pseudorabies Vaccine Revenue Market Share by Type (2020-2025)

Table 57. Global Swine Pseudorabies Vaccine Revenue Market Share by Type (2026-2031)

Table 58. Global Swine Pseudorabies Vaccine Price (US$/Box) by Type (2020-2025)

Table 59. Global Swine Pseudorabies Vaccine Price (US$/Box) by Type (2026-2031)

Table 60. Global Swine Pseudorabies Vaccine Sales (Box) by Application (2020-2025)

Table 61. Global Swine Pseudorabies Vaccine Sales (Box) by Application (2026-2031)

Table 62. Global Swine Pseudorabies Vaccine Sales Market Share by Application (2020-2025)

Table 63. Global Swine Pseudorabies Vaccine Sales Market Share by Application (2026-2031)

Table 64. Global Swine Pseudorabies Vaccine Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Swine Pseudorabies Vaccine Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Swine Pseudorabies Vaccine Revenue Market Share by Application (2020-2025)

Table 67. Global Swine Pseudorabies Vaccine Revenue Market Share by Application (2026-2031)

Table 68. Global Swine Pseudorabies Vaccine Price (US$/Box) by Application (2020-2025)

Table 69. Global Swine Pseudorabies Vaccine Price (US$/Box) by Application (2026-2031)

Table 70. Keqian Biology Company Information

Table 71. Keqian Biology Description and Business Overview

Table 72. Keqian Biology Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)

Table 73. Keqian Biology Swine Pseudorabies Vaccine Product

Table 74. Keqian Biology Recent Developments/Updates

Table 75. Zybio Company Information

Table 76. Zybio Description and Business Overview

Table 77. Zybio Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)

Table 78. Zybio Swine Pseudorabies Vaccine Product

Table 79. Zybio Recent Developments/Updates

Table 80. Jinyu Biology Company Information

Table 81. Jinyu Biology Description and Business Overview

Table 82. Jinyu Biology Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)

Table 83. Jinyu Biology Swine Pseudorabies Vaccine Product

Table 84. Jinyu Biology Recent Developments/Updates

Table 85. Cahic Company Information

Table 86. Cahic Description and Business Overview

Table 87. Cahic Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)

Table 88. Cahic Swine Pseudorabies Vaccine Product

Table 89. Cahic Recent Developments/Updates

Table 90. Pulike Biology Company Information

Table 91. Pulike Biology Description and Business Overview

Table 92. Pulike Biology Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)

Table 93. Pulike Biology Swine Pseudorabies Vaccine Product

Table 94. Pulike Biology Recent Developments/Updates

Table 95. Hayao Company Information

Table 96. Hayao Description and Business Overview

Table 97. Hayao Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)

Table 98. Hayao Swine Pseudorabies Vaccine Product

Table 99. Hayao Recent Developments/Updates

Table 100. Qilu Animal Protection Company Information

Table 101. Qilu Animal Protection Description and Business Overview

Table 102. Qilu Animal Protection Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)

Table 103. Qilu Animal Protection Swine Pseudorabies Vaccine Product

Table 104. Qilu Animal Protection Recent Developments/Updates

Table 105. Dahuanong Company Information

Table 106. Dahuanong Description and Business Overview

Table 107. Dahuanong Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)

Table 108. Dahuanong Swine Pseudorabies Vaccine Product

Table 109. Dahuanong Recent Developments/Updates

Table 110. Huapai Biotechnology Company Information

Table 111. Huapai Biotechnology Description and Business Overview

Table 112. Huapai Biotechnology Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)

Table 113. Huapai Biotechnology Swine Pseudorabies Vaccine Product

Table 114. Huapai Biotechnology Recent Developments/Updates

Table 115. Sinopharm Animal Health Company Information

Table 116. Sinopharm Animal Health Description and Business Overview

Table 117. Sinopharm Animal Health Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)

Table 118. Sinopharm Animal Health Swine Pseudorabies Vaccine Product

Table 119. Sinopharm Animal Health Recent Developments/Updates

Table 120. Tecon Company Information

Table 121. Tecon Description and Business Overview

Table 122. Tecon Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)

Table 123. Tecon Swine Pseudorabies Vaccine Product

Table 124. Tecon Recent Developments/Updates

Table 125. Zoetis Company Information

Table 126. Zoetis Description and Business Overview

Table 127. Zoetis Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)

Table 128. Zoetis Swine Pseudorabies Vaccine Product

Table 129. Zoetis Recent Developments/Updates

Table 130. Boehringer Ingelheim Company Information

Table 131. Boehringer Ingelheim Description and Business Overview

Table 132. Boehringer Ingelheim Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)

Table 133. Boehringer Ingelheim Swine Pseudorabies Vaccine Product

Table 134. Boehringer Ingelheim Recent Developments/Updates

Table 135. Bayer Company Information

Table 136. Bayer Description and Business Overview

Table 137. Bayer Swine Pseudorabies Vaccine Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2020-2025)

Table 138. Bayer Swine Pseudorabies Vaccine Product

Table 139. Bayer Recent Developments/Updates

Table 140. Key Raw Materials Lists

Table 141. Raw Materials Key Suppliers Lists

Table 142. Swine Pseudorabies Vaccine Distributors List

Table 143. Swine Pseudorabies Vaccine Customers List

Table 144. Swine Pseudorabies Vaccine Market Trends

Table 145. Swine Pseudorabies Vaccine Market Drivers

Table 146. Swine Pseudorabies Vaccine Market Challenges

Table 147. Swine Pseudorabies Vaccine Market Restraints

Table 148. Research Programs/Design for This Report

Table 149. Key Data Information from Secondary Sources

Table 150. Key Data Information from Primary Sources

Table 151. Authors List of This Report

List of Figures

Figure 1. Product Picture of Swine Pseudorabies Vaccine

Figure 2. Global Swine Pseudorabies Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Swine Pseudorabies Vaccine Market Share by Type: 2024 & 2031

Figure 4. Swine Pseudorabies Vaccine , Live Product Picture

Figure 5. Swine Pseudorabies　Vaccine, Inactivated Product Picture

Figure 6. Global Swine Pseudorabies Vaccine Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Swine Pseudorabies Vaccine Market Share by Application: 2024 & 2031

Figure 8. Farms

Figure 9. Individual

Figure 10. Global Swine Pseudorabies Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Swine Pseudorabies Vaccine Market Size (2020-2031) & (US$ Million)

Figure 12. Global Swine Pseudorabies Vaccine Sales (2020-2031) & (Box)

Figure 13. Global Swine Pseudorabies Vaccine Average Price (US$/Box) & (2020-2031)

Figure 14. Swine Pseudorabies Vaccine Report Years Considered

Figure 15. Swine Pseudorabies Vaccine Sales Share by Manufacturers in 2024

Figure 16. Global Swine Pseudorabies Vaccine Revenue Share by Manufacturers in 2024

Figure 17. Global 5 and 10 Largest Swine Pseudorabies Vaccine Players: Market Share by Revenue in Swine Pseudorabies Vaccine in 2024

Figure 18. Swine Pseudorabies Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 19. Global Swine Pseudorabies Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 20. North America Swine Pseudorabies Vaccine Sales Market Share by Country (2020-2031)

Figure 21. North America Swine Pseudorabies Vaccine Revenue Market Share by Country (2020-2031)

Figure 22. United States Swine Pseudorabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 23. Canada Swine Pseudorabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Europe Swine Pseudorabies Vaccine Sales Market Share by Country (2020-2031)

Figure 25. Europe Swine Pseudorabies Vaccine Revenue Market Share by Country (2020-2031)

Figure 26. Germany Swine Pseudorabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. France Swine Pseudorabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. U.K. Swine Pseudorabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Italy Swine Pseudorabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Russia Swine Pseudorabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Swine Pseudorabies Vaccine Sales Market Share by Region (2020-2031)

Figure 32. Asia Pacific Swine Pseudorabies Vaccine Revenue Market Share by Region (2020-2031)

Figure 33. China Swine Pseudorabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Japan Swine Pseudorabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. South Korea Swine Pseudorabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. India Swine Pseudorabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Australia Swine Pseudorabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. China Taiwan Swine Pseudorabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Indonesia Swine Pseudorabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Thailand Swine Pseudorabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Malaysia Swine Pseudorabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Swine Pseudorabies Vaccine Sales Market Share by Country (2020-2031)

Figure 43. Latin America Swine Pseudorabies Vaccine Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Swine Pseudorabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Swine Pseudorabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Swine Pseudorabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa Swine Pseudorabies Vaccine Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Swine Pseudorabies Vaccine Revenue Market Share by Country (2020-2031)

Figure 49. Turkey Swine Pseudorabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Swine Pseudorabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE Swine Pseudorabies Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of Swine Pseudorabies Vaccine by Type (2020-2031)

Figure 53. Global Revenue Market Share of Swine Pseudorabies Vaccine by Type (2020-2031)

Figure 54. Global Swine Pseudorabies Vaccine Price (US$/Box) by Type (2020-2031)

Figure 55. Global Sales Market Share of Swine Pseudorabies Vaccine by Application (2020-2031)

Figure 56. Global Revenue Market Share of Swine Pseudorabies Vaccine by Application (2020-2031)

Figure 57. Global Swine Pseudorabies Vaccine Price (US$/Box) by Application (2020-2031)

Figure 58. Swine Pseudorabies Vaccine Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions